129 related articles for article (PubMed ID: 3080018)
1. Evidence against a platelet cyclooxygenase defect in uraemic subjects on chronic haemodialysis.
Bloom A; Greaves M; Preston FE; Brown CB
Br J Haematol; 1986 Jan; 62(1):143-9. PubMed ID: 3080018
[TBL] [Abstract][Full Text] [Related]
2. Reduced platelet thromboxane formation in uremia. Evidence for a functional cyclooxygenase defect.
Remuzzi G; Benigni A; Dodesini P; Schieppati A; Livio M; De Gaetano G; Day SS; Smith WL; Pinca E; Patrignani P; Patrono C
J Clin Invest; 1983 Mar; 71(3):762-8. PubMed ID: 6298281
[TBL] [Abstract][Full Text] [Related]
3. Platelet dysfunction in uremia. Multifaceted defect partially corrected by dialysis.
Di Minno G; Martinez J; McKean ML; De La Rosa J; Burke JF; Murphy S
Am J Med; 1985 Nov; 79(5):552-9. PubMed ID: 3933340
[TBL] [Abstract][Full Text] [Related]
4. Differences in thromboxane production between neonatal and adult platelets in response to arachidonic acid and epinephrine.
Stuart MJ; Dusse J; Clark DA; Walenga RW
Pediatr Res; 1984 Sep; 18(9):823-6. PubMed ID: 6435080
[TBL] [Abstract][Full Text] [Related]
5. Regulation of human platelet activation--analysis of cyclooxygenase and cyclic AMP-dependent pathways.
Krishnamurthi S; Westwick J; Kakkar VV
Biochem Pharmacol; 1984 Oct; 33(19):3025-35. PubMed ID: 6091666
[TBL] [Abstract][Full Text] [Related]
6. Effect of cetiedil on platelet aggregation and thromboxane synthesis.
Yamaguchi A; Asakura T; Tanoue K; Yamazaki H
Thromb Res; 1985 Feb; 37(3):391-400. PubMed ID: 2986312
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of thromboxane B2 in uraemia and the effects of dialysis.
Winter M; Frampton G; Bennett A; Machin SJ; Cameron JS
Thromb Res; 1983 May; 30(3):265-72. PubMed ID: 6868024
[TBL] [Abstract][Full Text] [Related]
8. Glutathione disulfide production during arachidonic acid oxygenation in human platelets.
Burch JW; Burch PT
Prostaglandins; 1990 Feb; 39(2):123-34. PubMed ID: 2107565
[TBL] [Abstract][Full Text] [Related]
9. Miconazole inhibition of platelet aggregation by inhibiting cyclooxygenase.
Ishikawa S; Manabe S; Wada O
Biochem Pharmacol; 1986 Jun; 35(11):1787-92. PubMed ID: 3087363
[TBL] [Abstract][Full Text] [Related]
10. Cyclooxygenase and lipoxygenase metabolites during platelet aggregation: quantitative measurement by negative ion chemical ionization--gas chromatography/mass spectrometry.
Malle E; Nimpf J; Leis HJ; Wurm H; Gleispach H; Kostner GM
Prostaglandins Leukot Med; 1987 Apr; 27(1):53-70. PubMed ID: 3108905
[TBL] [Abstract][Full Text] [Related]
11. Licofelone, an inhibitor of cyclooxygenase and 5-lipoxygenase, specifically inhibits cyclooxygenase-1-dependent platelet activation.
Rotondo S; Krauze-Brzósko K; Manarini S; Evangelista V; Cerletti C
Eur J Pharmacol; 2004 Mar; 488(1-3):79-83. PubMed ID: 15044038
[TBL] [Abstract][Full Text] [Related]
12. [Effect of various stimulators on cyclooxygenase activity, platelet aggregation and TxB2 synthesis after using a platelet inhibitor (Aspro Clear) in vivo and in vitro].
Gorczynska E; James M; Wegrzynowicz R; Masiak M
Wiad Lek; 1985 Jul; 38(13):920-5. PubMed ID: 3933184
[No Abstract] [Full Text] [Related]
13. The effects of bicarbonate and acetate haemodialysis on platelet cyclic AMP concentration, thromboxane B2 release and aggregation.
Túri S; Bereczki C; Torday C; Havass Z; Németh M
Pediatr Nephrol; 1991 May; 5(3):327-31. PubMed ID: 1651098
[TBL] [Abstract][Full Text] [Related]
14. The effect of erythropoietin on platelet function in uraemic children on haemodialysis.
Turi S; Soos J; Torday C; Bereczki C; Havass Z
Pediatr Nephrol; 1994 Dec; 8(6):727-32. PubMed ID: 7696114
[TBL] [Abstract][Full Text] [Related]
15. Effects of diltiazem on thromboxane B2 production from platelet-rich plasma and whole blood.
Anfossi G; Trovati M; Mularoni E; Massucco P; Cavalot F; Mattiello L; Emanuelli G
Prostaglandins Leukot Essent Fatty Acids; 1991 Nov; 44(3):149-54. PubMed ID: 1808624
[TBL] [Abstract][Full Text] [Related]
16. Some properties of mouse platelets.
Rosenblum WI; Nelson GH; Cockrell CS; Ellis EF
Thromb Res; 1983 May; 30(4):347-55. PubMed ID: 6412387
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of platelet aggregation and reduced formation of thromboxane and lipoxygenase products in platelets by oil of cloves.
Srivastava KC; Justesen U
Prostaglandins Leukot Med; 1987 Sep; 29(1):11-8. PubMed ID: 3118394
[TBL] [Abstract][Full Text] [Related]
18. Influence of propranolol on platelet aggregation and thromboxane B2 production from platelet-rich plasma and whole blood.
Anfossi G; Trovati M; Mularoni E; Massucco P; Calcamuggi G; Emanuelli G
Prostaglandins Leukot Essent Fatty Acids; 1989 Apr; 36(1):1-7. PubMed ID: 2525784
[TBL] [Abstract][Full Text] [Related]
19. Influence of phentolamine on platelet aggregation, thromboxane B2 production and release reaction.
Anfossi G; Trovati M; Mularoni E; Lanzio M; Massucco P; Emanuelli G
Arch Int Pharmacodyn Ther; 1988; 296():144-54. PubMed ID: 2853612
[TBL] [Abstract][Full Text] [Related]
20. Regulation of arachidonate-induced platelet aggregation by the lipoxygenase product, 12-hydroperoxyeicosatetraenoic acid.
Aharony D; Smith JB; Silver MJ
Biochim Biophys Acta; 1982 Oct; 718(2):193-200. PubMed ID: 6814496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
